SERMON CHARLES (General Counsel) sold 20.1% of their position (46.39K shares) of MEREO BIOPHARMA GROUP PLC on the open market
Open‑market sale worth $161.7K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 6/27/2024ACC: 0000950170-24-078469
Officer· General Counsel
Since Feb 2026
-46.39K
Net shares
Net seller
$161.7K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
46.39K disposed
Non-Derivative Transactions2
American Depositary Shares representing Ordinary Shares
Direct
Shares
−14.20K
Price / share
$3.69
Trade value
$52.46K
% of position
6.2%
6/25/2024
230.78K→216.57K
American Depositary Shares representing Ordinary Shares
Direct
Shares
−32.19K
Price / share
$3.39
Trade value
$109.22K
% of position
14.9%
6/26/2024
216.57K→184.39K
Total
Net shares
−46.39K
Net value
-$161.68K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| American Depositary Shares representing Ordinary Shares Direct | 6/25/2024 | S · Sale | −14.20K | $3.69 | $52.46K | 6.2% | 230.78K | 216.57K |
| American Depositary Shares representing Ordinary Shares Direct | 6/26/2024 | S · Sale | −32.19K | $3.39 | $109.22K | 14.9% | 216.57K | 184.39K |
| Total | −46.39K | -$161.68K | ||||||
Derivative Transactions0
No derivative transactions reported